| Authors: |
Sharma S; Division of Neurodegenerative and Neurodevelopmental Disorders, St. Boniface Hospital Albrechtsen Research Centre, 351 Taché Ave, Winnipeg, MB, R2H 2A6, Canada., Cortés-Pérez C; Division of Neurodegenerative and Neurodevelopmental Disorders, St. Boniface Hospital Albrechtsen Research Centre, 351 Taché Ave, Winnipeg, MB, R2H 2A6, Canada., Bird S; Division of Neurodegenerative and Neurodevelopmental Disorders, St. Boniface Hospital Albrechtsen Research Centre, 351 Taché Ave, Winnipeg, MB, R2H 2A6, Canada., Di Curzio D; Division of Neurodegenerative and Neurodevelopmental Disorders, St. Boniface Hospital Albrechtsen Research Centre, 351 Taché Ave, Winnipeg, MB, R2H 2A6, Canada., Vandenakker A; Division of Neurodegenerative and Neurodevelopmental Disorders, St. Boniface Hospital Albrechtsen Research Centre, 351 Taché Ave, Winnipeg, MB, R2H 2A6, Canada., Schellenberg K; Division of Neurology, University of Saskatchewan, 3-616 10th St E, Saskatoon, SK, S7H 0G9, Canada., Douville RN; Division of Neurodegenerative and Neurodevelopmental Disorders, St. Boniface Hospital Albrechtsen Research Centre, 351 Taché Ave, Winnipeg, MB, R2H 2A6, Canada. reneenicole.douville@umanitoba.ca.; Department of Pharmacology and Therapeutics, University of Manitoba, 753 McDermot Ave, Winnipeg, MB, R3E 0T6, Canada. reneenicole.douville@umanitoba.ca. |